Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines. Developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)

Heart Rhythm

Volumn 6, Issue 6, 2009, Pages 869-885

  Maisel, William H ^a   Hauser, Robert G ^b   Hammill, Stephen C ^c   Ellenbogen, Kenneth A ^d   Epstein, Andrew E ^e   Hayes, David L ^c   Alpert, Joseph S ^f   Berger, Ronald D ^g   Curtis, Anne B ^h   Dubin, Anne M ⁱ   Estes III, N A Mark ^j   Gura, Melanie T ^k   Krahn, Andrew D ^l   Lampert, Rachel ^m   Lindsay, Bruce D ⁿ   Wilkoff, Bruce L ^o  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^c MAYO CLINIC   (United States)

^d Postmarket Surveillance of Pacemaker   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h UNIVERSITY OF SOUTH FLORIDA   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

^j TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k Stanford University ^*  (United States)

^l UNIVERSITY OF WESTERN ONTARIO   (Canada)

^m YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ AMERICAN COLLEGE OF CARDIOLOGY   (United States)

^o LERNER RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART PACEMAKER; DEFIBRILLATOR; FOOD AND DRUG ADMINISTRATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEART RHYTHM; HUMAN; MEDICAL SCHOOL; MEDICAL SOCIETY; POSTMARKETING SURVEILLANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

AMERICAN HEART ASSOCIATION; ARRHYTHMIAS, CARDIAC; CARDIAC PACING, ARTIFICIAL; CARDIOLOGY; HEALTH PLANNING GUIDELINES; HUMANS; PACEMAKER, ARTIFICIAL; UNITED STATES;

EID: 65749107941     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.04.024     Document Type: Review

References (74)

1. The Antiarrhythmic Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
2. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., and Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 (1996) 1933-1940
3. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., Andrews M.L., and Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
4. Kadish A., Dyer A., Daubert J.P., Ouigg R., Estes N.A., Anderson K.P., Calkins H., Hoch D., Goldberger J., Shalaby A., Sanders W.E., Schaechter A., and Levine J.H. Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2218
5. Gregoratos G., Abrams J., Epstein A.E., Freedman R.A., Hayes D.L., Hlatky M.A., Kerber R.E., Naccarelli G.V., Schoenfeld M.H., Silka M.J., Winters S.L., Gibbons R.I., Antman E.M., Alpert J.S., Hiratzka L.F., Faxon D.P., Jacobs A.K., Fuster V., and Smith Jr. S.C. American College of Cardiology/American Heart Association Task Force on Practice Guidelines American College of Cardiology/American Heart Association/North American Society for Pacing and Electrophysiology Committee. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. J Cardiovasc Electrophysiol 13 (2002) 1183-1199
6. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., Jessup M., Konstam M.A., Mancini D.M., Michl K., Oates J.A., Rahko P.S., Silver M.A., Stevenson L.W., and Yancy C.W. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation 112 (2005) 1825-1852
7. Epstein A.E., DiMarco J.P., Ellenbogen K.A., Estes III N.A.M., Freedman R.A., Gettes L.S., Gillinov A.M., Gregoratos G., Hammill S.C., Hayes D.L., Hlatky M.A., Newby L.K., Page R.L., Schoenfeld M.H., Silka M.J., Stevenson L.W., and Sweeney M.O. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation 117 (2008) 2820-2840
8. Hohnloser S.H., Kuck K.H., Dorian P., Roberts R.S., Hampton J.R., Hatala R., Fain E., Gent M., and Connolly S.J. DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488
9. Connolly S.J., Hallstrom A.P., Cappato R., Schron E.B., Kuck K.H., Zipes D.P., Greene H.L., Boczor S., Domanski M., Follmann D., Gent M., and Roberts R.S. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs. Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 21 (2000) 2071-2018
10. Kuck K.H., Cappato R., Siebels J., and Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102 (2000) 748-754
11. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., and Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341 (1999) 1882-1890
12. Connolly S.J., Gent M., Roberts R.S., Dorian P., Roy D., Sheldon R.S., Mitchell L.B., Green M.S., Klein G.J., and O'Brien B. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101 (2000) 1297-1302
13. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., McNulty S.E., Clapp-Channing N., Davidson-Ray L.D., Fraulo E.S., Fishbein D.P., Luceri R.M., and Ip J.H. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
14. Andersen H.R., Thuesen L., Bagger J.P., Vesterlund T., and Thomsen P.E. Prospective randomized trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 344 (1994) 1523-1528
15. Connolly S.J., Kerr C.R., Gen M., Roberts R.S., Yusif S., Gillis A.M., Sami M.H., Talajic M., Tang A.S.L., Klein G.J., Lau C., and Newman D.M. The Canadian Trial of Physiologic Pacing Investigators. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 342 (2000) 1385-1391
16. Lamas G.A., Lee K.L., Sweeney M., and Silverman R. Ventricular pacing or dual chamber pacing for sinus-node dysfunction. N Engl J Med 346 (2002) 1854-1862
17. Nielsen J.C., Kristense L., Andersen H.R., Mortensen P.T., Pedersen O.L., and Pedersen A.K. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome. J Am Coll Cardiol 42 (2003) 614-623
18. Linde C., Braunschweig F., Gadler F., et al. Long term improvements in quality of life by biventricular pacing in patients with chronic heart failure: results from the Multi-site Stimulation in Cardiomyopathy study (MUSTIC). Am J Cardiol 91 (2003) 1090-1099
19. Linde C., Leclercq C., Rex S., et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the Multisite Stimulation In Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 40 (2002) 111-118
20. St. John Sutton M.G., Plapper T., Abraham W.T., et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107 (2003) 1985-1990
21. Bristow M.R., Saxon L.A., Boehmer J., Krueger S., Kass D.A., DeMarco T., Carson P., DiCarlo L., DeMets D., White B.G., DeVries D.W., and Feldman A.M. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
22. Cleland J.G.F., Daubert J.-C., Erdmann E., Freemantle N., Gras D., Kappenberger L., and Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 (2005) 1539-1549
23. Abraham W.T., Young J.B., Leon A.R., et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator and mildly symptomatic chronic heart failure. Circulation 110 (2004) 2864-2868
24. Carlson M.D., Wilkoff B.L., Maisel W.H., Carlson M.D., Ellenbogen K.A., Saxon L.A., et al. Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines. Heart Rhythm 3 (2006) 1250-1273
25. Maloney J.D., Hayes D.L., and Timmis G.C. Report of the Policy Conference of NASPE on device/lead performance and the development of a postmarket surveillance database. Pacing Clin Electrophysiol 16 (1993) 1945-1953
26. Biotronik Cardiac Rhythm Management Product Performance Report July 2008. Accessed February 8, 2009. http://www.biotronik.com/sixcms/media.php/162/BIOTRONIK%20Product%20Perf ormance%20Report%20July%202008.pdf
27. Boston Scientific CRM Product Performance Report 2008 Q4 Summary Edition. Accessed on February 8, 2009. http://www.bostonscientific.com/templatedata/imports/HTML/CRM/Product_Pe rformance_Resource_Center/report_archives/q4_08_ppr.pdf
28. Medtronic Cardiac Rhythm Disease Management Product Performance Report 2008 Second Edition Issue 59. Accessed February 8, 2009. http://www.medtronic.com/crm/performance/downloads/mdt-prod-performance- 2008-2-en.pdf
29. Sorin Group. Cardiac Rhythm Management Product Performance Report. November 2008 Edition. Accessed February 8, 2009. http://www.sorin-crm.com/uploads/Media/pprmay2008worldwide.pdf
30. St. Jude Medical Cardiac Rhythm Management Product Performance Report. October 2008. Accessed February 8, 2009. http://www.sjm.com/_MediaAssets/documents/ppr.pdf
31. Moller M., and Arnsbro P. Danish Pacemaker and ICD Register 2006. Accessed February 8, 2009. www.pacemaker.dk/stat2006.pdf
32. Eckstein J., Koller M.T., Zabel M., Kalusche D., Schaer B.A., Osswald S., and Sticherling C. Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation 117 (2008) 21 :2727-2733
33. Kron J., Herre J., Renfroe E.G., Rizo-Patron C., Raitt M., Halperin B., Gold M., Goldner B., Wathen M., Wilkoff B., Olarte A., and Yao Q. Lead- and device-related complications in the Antiarrhythmics Versus Implantable Defibrillators trial. Am Heart J 141 (2001) 92-98
34. Luria D., Glikson M., Brady P.A., Lexvold N.Y., Rasmussen M.J., Hodge D.O., Chugh S.S., Rea R.F., Hayes D.L., Hammill S.C., and Friedman P.A. Predictors and mode of detection of transvenous lead malfunction in implantable defibrillators. Am J Cardiol 87 (2001) 901-904
35. Hauser R.G., Cannom D., Hayes D.L., Parsonnet V., Hayes J., Ratliff III N., Tyers G.F., Epstein A.E., Vlay S.C., Furman S., and Gross J. Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads. Pacing Clin Electrophysiol 25 (2002) 879-882
36. Ellenbogen K.A., Wood M.A., Shepard R.K., Clemo H.F., Vaughn T., Holloman K., Dow M., Leffler J., Abeyratne A., and Verness D. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol 41 (2003) 73-80
37. Kitamura S., Satomi K., Kurita T., Shimizu W., Suyama K., Aihara N., Niwaya K., Kobayashi J., and Kamakura S. Long-term follow-up of transvenous defibrillation leads: high incidence of fracture in coaxial polyurethane lead. Circ J 70 (2006) 273-277
38. Aass H., and Ilvento J. Short and medium time experience with a tined, multilumen steroid eluting defibrillation lead. J Interv Card Electrophysiol 6 (2002) 81-86
39. Dorwarth U., Frey B., Gugas M., Matis T., Fiek M., Schmoeckel M., Remp P., Durchlaub I., Gerth A., Steinbeck G., and Hoffmann E. Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol 14 (2003) 38-43
40. Kleemann T., Becker T., Doenges K., Vater M., Senges J., Schneider S., Saggau W., Weisse U., and Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of 10 years. Circulation 115 (2007) 2474-2480
41. Maisel W.H., and Kramer D.B. Implantable cardioverter-defibrillator lead performance. Circulation 117; (2008) 2721-2723
42. Advanced Medical Technologies Association. Proposal for Comment. Industry Guidance: Uniform Reporting of Clinical Performance of Cardiac Rhythm Management Pulse Generators and Leads. Accessed February 8, 2009. http://www.advamed.org/NR/rdonlyres/A7788EB0-9484-43F4-8423-A669E62D707D /0/AdvaMedProposalUniformreportingforPGsand Leadsv20120308.pdf
43. Maisel W.H., and Hauser R.G. Proceedings of the ICD Lead Performance Conference. Heart Rhythm 5 (2008) 1331-1338
44. Department of Health and Human Services: Postmarket Surveillance: Final rule. Federal Register 67 (2002) 38878-38892
45. Improving patient care by reporting problems with medical devices. Med Watch. Department of Health and Human Services. Food and Drug Administration, HF-2, Rockville, Maryland, September 1997.
46. Institute of Medicine. Safe Medical Devices for Children. The National Academy of Sciences. July 18, 2005. http://www.iom.edu/CMS/3740/18614/28277.aspx
47. Kirkpatrick J.N., Burke M.C., and Knight B.P. Postmortem analysis and retrieval of implantable pacemakers and defibrillators (letter). N Engl J Med 354 (2006) 1649-1650
48. U.S. Food and Drug Administration, and Center for Devices and Radiological Health. Medical Product Safety Network. About MedSun. Accessed February 8, 2009. http://www.fda.gov/cdrh/medsun/about.html
49. U.S. Food and Drug Administration, and Center for Devices and Radiological Health. Medical Product Safety Network. MedSun Reports. Accessed February 8, 2009. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/medsun/SearchReportTex t.cfm?dls=1&q=lead&pf=Data_Date_Year:2008&pn=5&sc=D.repo rtDate%20DESC
50. Pratt T.R., Pulling C.C., and Stanton M.S. Prospective postmarket device studies versus returned product analysis as a predictor of system survival. Pacing Clin Electrophysiol 23 (2000) 1150-1155
51. Maisel W.H. Transvenous Implantable cardioverter-defibrillator leads: the weakest link. Circulation 115 (2007) 2461-2463
52. Furman S., and Escher D.J. Transtelephonic pacemaker monitoring. In: Schaldach M., and Furman S. (Eds). Advances in Pacemaker Technology (1975), Springer, Berlin 177-194
53. Wilkoff B.L., Auricchio A., Brugada J., Cowie M., Ellenbogen K.A., Gillis A.M., Hayes D.L., Howlett J.G., Kautzner J., Love C.J., Morgan J.M., Priori S.G., Reynolds D.W., Schoenfeld M.H., and Vardas P.E. HRS/EHRA Expert Consensus on the monitoring of cardiovascular implantable electronic devices (CIED): description of the techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm 5 (2008) 907-925
54. Marzegalli M., Lunati M., Landolina M., Perego G.B., Ricci R.P., Guenzati G., et al. Remote monitoring of CRT-ICD: The Multicenter Italian Carelink Evaluation-Ease of use, acceptance, and organizational implications. Pacing Clin Electrophysiol 31 (2008) 1259-1264
55. Kallinen L.M., Hauser R.G., Lee K.W., Almquist A.D., Katsiyiannis W.T., Tang C.Y., Melby D.P., and Gornick C.C. Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm 5 (2008) 775-777
56. Standards for Privacy of Individually Identifiable Health Information. Final Rule. 45 CFR parts 160 and 164. Accessed April 6, 2009. http://www.hhs.gov/ocr/privacy/hipaa/administrative/privacyrule/adminsim pregtext.pdf
57. Institute of Medicine. Beyond the HIPAA Privacy Rule: Enhancing Privacy, Improving Health Through Research (2009), National Academy Press, Washington DC
58. Gostin L.O., and Nass S. Reforming the HIPAA Privacy Rule: safeguarding privacy and promoting research. JAMA 301 (2009) 1373-1375
59. Hammill S.C., Kremers M.S., Stevenson L.W., Kadish A.H., Heidenreich P.A., Lindsay B.D., et al. National ICD Registry Annual Report 2007: review of the registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm 5 (2008) 1359-1363
60. Berul C.I., Van Hare G.F., Kertesz N.J., Dubin A.M., Cecchin F., Collins K.K., et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart patients. J Am Coll Cardiol 51 (2008) 1685-1691
61. Gould P.A., Krahn A.D., and Canadian Heart Rhythm Society Working Group on Device Advisories. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA 295 (2006) 1907-1911
62. Amin M.S., Matchar D.B., Wood M.A., and Ellenbogen K. Management of recalled pacemakers and implantable cardioverter-defibrillators: a decision analysis model. JAMA 296 (2006) 412-420
63. Murray C.M., Germany R.E., Bright B.C., et al. Device "recall" terminology: results of a patient survey. Heart Rhythm 5 (2008) S45
64. Wolgalter M.S., and Cowley J.A. An examination of potential names for a recall notification campaign. Accessed February 8, 2009. http://www.fda.gov/ohrms/dockets/ac/08/slides/2008-4347s2-03.pdf
65. Heart Rhythm Society. Late Breaking Clinical Trial Results Announced at Heart Rhythm 2008: PREFER Trial. Accessed February 8, 2009. http://www.hrsonline.org/News/Media/press-releases/prefer_trial.cfm
66. Maisel W.H. Physician management of pacemaker and implantable cardioverter defibrillator advisories. Pacing Clin Electrophysiol 27 (2004) 1-6
67. Klug D., Balde M., Pavin D., Hidden-Lucet F., Clementy J., Sadoul N., et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators. Circulation 116 (2007) 1349-1355
68. Epstein L.M., Byrd C.L., Wilkoff B.L., et al. Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads. Circulation 100 (1999) 516-525
69. Glikson M., Suleiman M., Luria D.M., Martin M.L., Hodge D.O., Shen W.-K., et al. Do abandoned leads pose risk to implantable cardioverter-defibrillator patients?. Heart Rhythm 6 (2009) 65-68
70. Kay G.N., Brinker J.A., Kawanishi D.T., Love C.J., Lloyd M.A., Reeves R.C., et al. ; for the Accufix Multicenter Clinical Study Investigators. Risks of spontaneous injury and extraction of an active fixation pacemaker lead. Circulation 100 (1999) 2344-2352
71. Swerdlow C.D., Gunderson B.D., Ousdigian K.T., Abeyratne A., Stadler R.W., Gillberg J.M., et al. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads. Circulation 118 (2008) 2122-2129
72. Berul C.I., Van Hare G.F., Kertesz N.J., et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 51 (2008) 1685-1691
73. Link M.S., Hill S.L., Cliff D.L., et al. Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. Am J Cardiol 83 (1999) 263-266 A5-A6
74. Fortescue E.B., Berul C.I., Cecchin F., Walsh E.P., Triedman J.K., and Alexander M.E. Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. Heart Rhythm 1 (2004) 150-159